While traditionally considered first-line therapy, current American Diabetes Association guidance emphasizes a person-centered approach to initial medication selection based on comorbidities, treatment goals, and patient preferences
For individuals managing weight through GLP-1 therapy, blood sugar instability can trigger cravings, fatigue, and impaired decision-making around food choicesexactly the patterns you're working to break
Common side effects include: Nausea (the most common, usually first to emerge) Vomiting Diarrhea Constipation Abdominal pain or discomfort Semaglutide is also associated with serious but less common side effects that require prompt medical attention, which makes clinician oversight essential
Semaglutide or GLP-1 receptor agonists should be the preference, as the data does not support lipotropic injections for significant weight loss, Dr
Shima Hadidchi , a board-certified primary care physician serving the Apple Valley and Victorville communities, believes that accessible, effective healthcare is the cornerstone of a healthier and happier life